B02BD02 • octocog alfa • Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors
Octocog alfa is a recombinant factor VIII used for the treatment and prevention of bleeding episodes in patients with hemophilia A. It replaces the missing or deficient factor VIII, which is essential for blood clotting.
The medication is administered intravenously, as directed by your doctor, usually during bleeding episodes or prophylactically to prevent bleeds. It is important to follow the recommended treatment regimen.
Side effects may include injection site reactions, fever, headache, or, in rare cases, severe allergic reactions.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of octocog alfa.
Substance: octocog alfa
Date of last drug list: 01-03-2017
Commercial code: W63302001
Concentration: 500UI / 10ml
Pharmaceutical form: powder+solvent for injection
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).